RecruitingNCT00271180
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Medtronic CRDM Product Performance Report
Sponsor
Medtronic
Enrollment
20,000 participants
Start Date
Jan 1, 1983
Study Type
OBSERVATIONAL
Conditions
Summary
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Eligibility
Plain Language Summary
Simplified for easier understanding
This long-term study tracks how well Medtronic heart devices (such as pacemakers and defibrillators) perform over time in real-world patients.
**You may be eligible if...**
- You are about to receive, or recently received (within 30 days), a Medtronic heart rhythm device such as a pacemaker or defibrillator
- You previously took part in a Medtronic clinical study and your data is available for follow-up
- You or your legal guardian can provide written consent
**You may NOT be eligible if...**
- You cannot be reached for follow-up visits
- Local laws in your region restrict your participation
- Your device was implanted at a hospital not participating in the study
- The enrollment limit for your specific device model has already been reached
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDevice
Locations(333)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00271180
Related Trials
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060953 locations
Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
NCT068962664 locations
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
NCT072320302 locations
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
NCT02880618
RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases
NCT07491237